Cargando…
THU055 The Acro-TIME Score: A New Clinical, Pathological And Immune Integrative Approach To Early Identify Acromegaly Patients Resistant To Treatment With First Generation Somatostatin Ligands
Disclosure: S. Chiloiro: None. A. Giampietro: None. M. Gessi: None. L. Lauretti: None. M. Pier Paolo: None. A. Carlino: None. A. Olivi: None. G. RIndi: None. A. Pontecorvi: None. L. De Marinis: None. F. Doglietto: None. A. Bianchi: None. Introduction: Somatotropinomas are benign neoplasia, with a he...
Autores principales: | Chiloiro, Sabrina, Giampietro, Antonella, Gessi, Marco, Lauretti, Liverana, Paolo, Mattogno Pier, Carlino, Angela, Olivi, Alessandro, RIndi, Guido, Pontecorvi, Alfredo, De Marinis, Laura, Doglietto, Francesco, Bianchi, Antonio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10553649/ http://dx.doi.org/10.1210/jendso/bvad114.1135 |
Ejemplares similares
-
THU050 The Role Of The GH Receptor Polymorphism As Prognostic Factor Of Vertebral Fractures In Acromegaly Patients Resistant To First Generation SSAs And Treated With GH Receptor Antagonist Or Second Generation Somatostatin Ligand
por: Costanza, Flavia, et al.
Publicado: (2023) -
SUN-LB076 Potential Role of Gallium-68-Peptides and Fluorine-18-FDG PET/CT and Ki67 in Patients with Post-Surgical Residual Pituitary Adenoma
por: Chiloiro, Sabrina, et al.
Publicado: (2019) -
MON-311 Glucose Metabolism in Acromegaly Patients Resistant to First Generation Somatostatin Receptor Ligands Treated with Pegvisomant And/Or Pasireotide Lar
por: Chiloiro, Sabrina, et al.
Publicado: (2020) -
SUN-LB075 Effects of Pegvisomant and Pasireotide LAR on Incidence of Vertebral Fractures in Patients with Acromegaly Resistant to Treatment with First-Line Somatostatin Analogs
por: Chiloiro, Sabrina, et al.
Publicado: (2019) -
THU025 Acromegaly And Central Hyperthyroidism
por: Akhtar, Ahmad, et al.
Publicado: (2023)